Bowel Cancer Origin: “Big Bang” Discovery & Disease Start

Every year, over 1.9 million people are diagnosed with colorectal cancer globally. But what if we could pinpoint the very moment this disease truly takes hold – a ‘Big Bang’ of genetic and epigenetic changes that dictates its future trajectory? Recent breakthroughs are revealing precisely that, offering a revolutionary new lens through which to understand, … Read more

Lactate & Cancer: Metabolic Shift Fuels Tumor Growth

Lactate and Lactylation: Emerging Roles in Cancer Metabolism and Epigenetics Groundbreaking research is revealing a surprising connection between lactate, traditionally viewed as a waste product of metabolism, and the progression of various cancers. Scientists are discovering that lactate and a process called lactylation – the addition of a lactate molecule to proteins – actively drive … Read more

mRNA Vaccines: Boosting Cancer Drug Immunity & Response

mRNA Vaccines Show Promise in Boosting Cancer Treatment Response Groundbreaking research suggests that mRNA technology, initially developed for COVID-19 vaccines, may hold the key to enhancing the effectiveness of cancer therapies. A growing body of evidence indicates that these vaccines can stimulate the immune system to more effectively target and destroy cancer cells, offering a … Read more

Bladder Cancer: New Hope & Improved Outcomes 🎗️

Breakthroughs in Bladder Cancer Treatment Offer New Hope to Thousands Recent advancements in bladder cancer therapies, including innovative perioperative strategies and immunotherapy combinations, are significantly improving patient outcomes and extending disease-free survival rates. New treatments are also emerging for those unable to undergo traditional chemotherapy, offering a vital lifeline for a broader range of patients. … Read more

Budigalimab & HIV: PD-1 Blockade Safety & Early Effects

Budigalimab Shows Promise in Delaying HIV Viral Rebound During Treatment Interruption In a significant development for HIV research, a new study indicates that the experimental drug budigalimab may offer a novel approach to controlling the virus. Early trial results reveal that budigalimab, a PD-1 inhibitor, was well-tolerated by participants and demonstrated the ability to delay … Read more

Colon Cancer: New Immunotherapy Hope for Liver Mets

Breakthrough Immunotherapy Shows Promise in Eradicating Colon Cancer Liver Metastases February 29, 2024 – A team of researchers at the University of California, San Francisco (UCSF) has announced a significant advancement in the fight against colorectal cancer, specifically in treating liver metastases – a common and often deadly complication of the disease. A novel immunotherapy … Read more